Gapping up
In reaction to strong earnings/guidance:
- SCON +6.2%, ALTR +3.3%, EGO +1%, LE +0.9%
Other news:
- OMER +28% (spending bill includes segment allowing company to charge Medicare high prices for its cataract surgery drug Omidria)
- TTNP +21.5% (executes agreement for acquisition by Molteni of Probuphine in Europe and other select territories; received initial payment of €2.0 mln and will receive potential additional payments totaling up to €4.5 mln )
- MNGA +13.4% (has made a non-refundable deposit of $1.0 million toward the purchase of Trico Welding Supplies)
- GERN +7.6% (continued strength)
- TELL +7.2% (Bechtel has made a $50 million zero coupon preferred equity investment in Tellurian which has an implied Tellurian common share price of $8.16 per share)
- MGPI +4.5% (will replace Evercore the S&P SmallCap 600)
- TRHC +3.7% (ticking higher; to join S&P SmallCap 600)
Analyst comments:
- BWA +1.4% (upgraded to Overweight from Underweight at Morgan Stanley)